Summary
AFTER YEARS OF WATCHING the sales of blockbuster drugs plunge as soon as they went off patent, major pharmaceutical companies are adopting hard-hitting new tactics to fight back. Merck and Pfizer opened a major new front in the battle against generic drugmakers when Merck slashed the price of its cholesterol-lowering Zocor and Pfizer unveiled plans to roll out a generic version of its antidepressant Zoloft.
See the full content of this document
Extract
Revolution in Drug Prices
AFTER YEARS OF WATCHING the sales of blockbuster drugs plunge as soon as they ...
See the full content of this document
Sponsored links
